Browse Research Interests
 | | |
|---|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
| Dr Timothy Dobbins
Prince of Wales Clinical SchoolStatement of Interests:
Enjoys applying statistical methods to guide research in health and medicine. The design and analysis of cluster randomsied trials is a particular research interest.
More...
| |
| Associate Professor Bettina Meiser
Prince of Wales Clinical SchoolStatement of Interests:
An ongoing research program that incorporates both qualitative and quantitative research methodologies focuses on the psychological impact of genetic testing and counselling for adult-onset disorders, in particular cancer susceptibility; psychological adjustment of those at risk for adult-onset disorders; the design and evaluation of interventions in the genetic counselling setting, in particular decision aids as an innovative means of patient education; and the impact of prophylactic surgery in individuals at high risk for cancer. Another area of research is cultural aspects of cancer genetics.
More...
| |
| Dr Sallie-Anne Pearson
Prince of Wales Clinical SchoolStatement of Interests:
Sallie is a health service researcher specialising in clinician behaviour change, pharmacoepidemiology and pharmaceutical policy evaluation. She has conducted this research in Australia, the United States and the developing world. Sallie completed her doctoral training in 1998 at the University of Newcastle, Australia and was the inaugural Postdoctoral Fellow in Pharmaceutical Policy at Harvard Medical School from 2000-2001. She returned to Australia in 2002 where she worked as a consultant to the WHO Collaborating Centre in Pharmaceutical Policy Boston and Medicare Australia for two years. She returned to academia in 2004 and in March 2006 joined the Integrated Cancer Research Group as the Pharmacoepidemiology and Pharmaceutical Policy Team Leader. She is currently a Cancer Institute NSW Health Services Research Fellow (2006-2009). Sallie's current research interests focus on three core areas: 1. Using secondary data sources to investigate the use and impact of medicines in real world clinical prcatice 2. Clinician behaviour change, specifically the use and uptake of electronic decision support to guide prescribing practice 3. Investigating the direct and indirect costs of cancer care from the perspective of health care payers and patients
More...
| |
| Dr Claire Vajdic
Prince of Wales Clinical SchoolStatement of Interests:
The epidemiology of cancer in relation to immunodeficient states, such as HIV/AIDS infection, solid organ transplantation, haematopoietic stem cell transplantation, and primary immune deficiency. The epidemiology and prevention of cancer, in particular lymphoma. Epidemiological methods, with an emphasis on exposure assessment. Ongoing interest in malignancies associated with sun exposure, in particular, melanoma of the eye.
More...
| |
| Professor Susan Wilson
Prince of Wales Clinical SchoolStatement of Interests:
Development and application of novel statistical approaches to analysis of complex genomic data
More...
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |